Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-03-12

Clinical Trial Update: Low-Dose Risperidone Treatment for Subjects Suffering From Borderline Personality Disorder [NA]

View source ↗

Summary

Clinical trial update for low-dose risperidone treatment in subjects with borderline personality disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Borderlone Personality Disorder | NA | Status: UNKNOWN